Cargando…

Combining RNA interference and kinase inhibitors against cell signalling components involved in cancer

BACKGROUND: The transcription factor activator protein-1 (AP-1) has been implicated in a large variety of biological processes including oncogenic transformation. The tyrosine kinases of the epidermal growth factor receptor (EGFR) constitute the beginning of one signal transduction cascade leading t...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Grady, Michael, Raha, Debasish, Hanson, Bonnie J, Bunting, Michaeline, Hanson, George T
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1262698/ https://www.ncbi.nlm.nih.gov/pubmed/16202132 http://dx.doi.org/10.1186/1471-2407-5-125

Ejemplares similares

Combinations of Kinase Inhibitors Protecting Myoblasts against Hypoxia
por: Kang, Yunyi, et al.
Publicado: (2015)

Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome
por: Soltan, Mohamed A., et al.
Publicado: (2023)

The OpdQ porin of Pseudomonas aeruginosa is regulated by environmental signals associated with cystic fibrosis including nitrate‐induced regulation involving the NarXL two‐component system
por: Fowler, Randal C., et al.
Publicado: (2015)

Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer
por: Ragusa, Francesca, et al.
Publicado: (2022)

Consideration of Kinase Inhibitors for the Treatment of Hydrocephalus
por: Blazer-Yost, Bonnie L.
Publicado: (2023)

Establishing an In Vivo Assay System to Identify Components Involved in Environmental RNA Interference in the Western Corn Rootworm
por: Miyata, Keita, et al.
Publicado: (2014)

Two sides of the same coin: tyrosine kinase inhibition in cancer and neurodegeneration
por: Hebron, Michaeline, et al.
Publicado: (2015)

Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy
por: Gonzales, A J, et al.
Publicado: (2014)

Autoimmune targeting of key components of RNA interference
por: Jakymiw, Andrew, et al.
Publicado: (2006)

Neonicotinoids Interfere with Specific Components of Navigation in Honeybees
por: Fischer, Johannes, et al.
Publicado: (2014)

Helping boys at-risk of criminal activity: qualitative results of a multi-component intervention
por: Lipman, Ellen L, et al.
Publicado: (2011)

Reflections from a Patient and Carer on Involvement in Research and Integrating Care in the Health System
por: Hanson, Frank, et al.
Publicado: (2017)

Cerium Oxide Nanoparticles Protect against Oxidant Injury and Interfere with Oxidative Mediated Kinase Signaling in Human-Derived Hepatocytes
por: Carvajal, Silvia, et al.
Publicado: (2019)

Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma
por: Kwok, Christopher, et al.
Publicado: (2023)

Combining RNA Interference Mutants and Comparative Proteomics to Identify Protein Components and Dependences in a Eukaryotic Flagellum
por: Portman, Neil, et al.
Publicado: (2009)

Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review
por: Zhao, Melody, et al.
Publicado: (2023)

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
por: Chen, Gang, et al.
Publicado: (2012)

Nuclear Outsourcing of RNA Interference Components to Human Mitochondria
por: Bandiera, Simonetta, et al.
Publicado: (2011)

Dysregulation of RNA interference components in COVID-19 patients
por: Mousavi, Seyyed Reza, et al.
Publicado: (2021)

Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients
por: Jennings, C J, et al.
Publicado: (2015)

Kinase Inhibitors in Genetic Diseases
por: D’Antona, Lucia, et al.
Publicado: (2023)

Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors
por: Sim, Jongmin, et al.
Publicado: (2018)

RNA interference against polo-like kinase-1 in advanced non-small cell lung cancers
por: Kawata, Eri, et al.
Publicado: (2011)

Correction to: Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
por: Chen, Gang, et al.
Publicado: (2020)

A Small Molecule Inhibitor of Bruton’s Tyrosine Kinase Involved in B-Cell Signaling
por: Ratzon, Einav, et al.
Publicado: (2017)

P2Y(1) receptor modulation of endogenous ion channel function in Xenopus oocytes: Involvement of transmembrane domains
por: Lee, So Yeong, et al.
Publicado: (2004)

Development of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine
por: Liu, Minghua, et al.
Publicado: (2017)

Two-component interference effect in one- and two-dimensional systems
por: Streda, Pavel, et al.
Publicado: (2001)

Combination therapy with copanlisib and ABL tyrosine kinase inhibitors against Philadelphia chromosome-positive resistant cells
por: Okabe, Seiichi, et al.
Publicado: (2016)

Efficacy of the polo-like kinase inhibitor rigosertib, alone or in combination with Abelson tyrosine kinase inhibitors, against break point cluster region-c-Abelson-positive leukemia cells
por: Okabe, Seiichi, et al.
Publicado: (2015)

MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975
por: Tang, Minhong, et al.
Publicado: (2022)

RNA Interference Screen Identifies Abl Kinase and PDGFR Signaling in Chlamydia trachomatis Entry
por: Elwell, Cherilyn A., et al.
Publicado: (2008)

The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer
por: Purcaru, Oana-Stefana, et al.
Publicado: (2021)

Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy
por: Joshi, Avadhut D., et al.
Publicado: (2012)

Change in Work–Time Control and Work–Home Interference Among Swedish Working Men and Women: Findings from the SLOSH Cohort Study
por: Leineweber, Constanze, et al.
Publicado: (2016)

RNA-Interference Components Are Dispensable for Transcriptional Silencing of the Drosophila Bithorax-Complex
por: Cernilogar, Filippo M., et al.
Publicado: (2013)

Interferences from blood collection tube components on clinical chemistry assays
por: Bowen, Raffick A.R., et al.
Publicado: (2014)

Optimal interference of the tibial component of the cementless Oxford Unicompartmental Knee Replacement
por: Campi, S., et al.
Publicado: (2018)

Interference with thyroid histogenesis by inhibitors of collagen synthesis
Publicado: (1977)

Protease inhibitors interfere with the necessary factors of carcinogenesis.
por: Troll, W
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_e14bil9bd214l2ienqunhpb8um